GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2351 - 2375** of **4050** in total

« First

‹ Prev

…

91

92

93

94

95

96

97

98

99

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	24	mild	G52880ZN	31
IgM	Patient 2	15	mild	G52880ZN	95
IgM	Patient 2	24	mild	G52880ZN	95
IgG	Patient 1	6	moderate	G52880ZN	28
IgM	Patient 1	6	moderate	G52880ZN	40
IgA	Patient 2	3	mild	G52880ZN	383
IgG	Patient 2	3	mild	G52880ZN	39
IgM	Patient 2	3	mild	G52880ZN	153
IgA	Patient 3	-180	mild	G52880ZN	297
IgA	Patient 3	11	mild	G52880ZN	431
IgG	Patient 3	-180	mild	G52880ZN	81
IgM	Patient 3	-180	mild	G52880ZN	92
IgA	Patient 3	4	mild	G52880ZN	423
IgG	Patient 3	11	mild	G52880ZN	97
IgG	Patient 3	4	mild	G52880ZN	97
IgM	Patient 3	11	mild	G52880ZN	76
IgM	Patient 3	4	mild	G52880ZN	87
IgA	Patient 4	12	mild	G52880ZN	415
IgG	Patient 4	12	mild	G52880ZN	87
IgM	Patient 4	12	mild	G52880ZN	148
IgA	Patient 1	10	moderate	G53168IY	431
IgA	Patient 1	22	moderate	G53168IY	427
IgA	Patient 1	6	moderate	G53168IY	383
IgG	Patient 1	10	moderate	G53168IY	25
IgG	Patient 1	22	moderate	G53168IY	40